Evidence map›Paper›PMID 26590950›Full record

Trial reportEuropean journal of drug metabolism and pharmacokinetics2016

Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.

Marianela Lorier, Laura Magallanes, Manuel Ibarra, Natalia Guevara, Marta Vázquez, Pietro Fagiolino

Abstract readClinical TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in European journal of drug metabolism and pharmacokinetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marianela LorierDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay.
Laura MagallanesDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay.
Manuel IbarraDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay.
Natalia GuevaraDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay.
Marta VázquezDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay.
Pietro FagiolinoDepartment of Pharmaceutical Sciences, Faculty of Chemistry, Universidad de la República, P. O. Box 1157, 11800, Montevideo, Uruguay. pfagioli@fq.edu.uy.
Universidad de la República · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesKetoprofen, a potent nonsteroidal anti-inflammatory drug, is clinically administered as a racemic mixture. One of the possible metabolism routes of ketoprofen is the inversion of the R- to S-enantiomer in the gastrointestinal tract. Ketoprofen, as a weak acid drug, might undergo recirculation through pancreatic/intestinal juices. The aim of the work was to investigate if a plasma-gastrointestinal tract recirculation of ketoprofen could explain its R-to-S chiral inversion after the oral administration of two modified-release formulations: a gastro-resistant delayed-release tablet (Reference) and an extended-release-plus-immediate-release bilayer tablet (Test).

methodsSixteen healthy Caucasian volunteers (eight women and eight men) participated in a ketoprofen bioequivalence study. Both formulations were administered with and without food. In both cases, standard meals were given throughout the experiment. R- and S-enantiomers were measured separately using a validated HPLC-UV chiral method. Mean concentration-time profiles of ketoprofen enantiomers in plasma were obtained for men and women. Area under the plasma concentration-time curve, maximum ketoprofen plasma concentration, and time-to-peak were also computed for both isomers, both modes of administration, and both sexes. S/R concentration ratio was assessed as an indicator of enantiomer chiral inversion rate.

resultsDifferences in the pharmacokinetics of S- and R-ketoprofen enantiomers were found after the Test administration. S-Ketoprofen presented a lower plasma exposure compared to R-enantiomer. However, the S/R concentration ratio increased 1 h (in men) and 2 h (in women) after meal intakes. This was related to pancreatic and/or intestinal and/or biliary secretions of the drug, followed by reabsorption and conversion of the R- to the S-isomer. The lower intestinal pH reported for men would lead to a higher oral bioavailability of the Test formulation and a higher reabsorption of both ketoprofen isomers in this sex. Hence, a higher rise of the S/R concentration ratio could be observed in men. No significant differences between isomers exposure were detected in both sexes after the Reference administration. Different lag times were observed after fed and fasting administration of this formulation; however, drug absorption coincided with food ingestion. Then, drug recirculation affected the S/R ratio from the beginning of drug exposure, minimizing the difference between isomers disposition.

conclusionsR-to-S conversion rate could be mainly associated with several passages of the drug through the intestinal mucosa. The concentration-time profiles of ketoprofen in plasma after the administration of both formulations evidenced R-to-S conversion of recirculating drug following meal intakes.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsDrug CompoundingKetoprofenAdministration, OralAdultArea Under CurveBiological AvailabilityBiotransformationCross-Over StudiesDelayed-Action PreparationsFemaleFood-Drug InteractionsHumansIntestinal AbsorptionMaleAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsDelayed-Action PreparationsKetoprofenTablets, Enteric-Coated

Identifiers

PMID26590950
OpenAlexW2255250234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.